Christine Prosser

Principal Scientist, UCB

About Christine ProsserCristine Prosser

Christine has been working in the Physical and Analytical Sciences Group at the biopharmaceutical company UCB since leaving school in 1999. Initially her role was to provide liquid chromatography, mass spectrometry and physicochemical profiling support to Medicinal Chemistry whose aim is to develop new medicines for patients with inflammatory diseases, such as rheumatoid arthritis and psoriasis, and CNS diseases, such as epilepsy and Parkinson’s disease.

In 2005, Christine gained a First Class Honours Degree in Chemistry after studying part-time for 5 years. In 2010, she started a part-time PhD with Professor Mark Carr at the University of Leicester. Her research focused on antibody structure and function, in particular a novel type of antibody found in camels and llamas. After completing her PhD, she was awarded an Honorary Visiting Fellow position with the university. Her work at UCB has shifted her away from analytical chemistry to structural biology.

There is a long running collaboration between UCB and the University of Leicester with Mark Carr’s group providing NMR and structural biology support for UCB projects. Christine now heads up this collaboration. She is heavily involved with the Antibody Assisted Drug Discovery Consortium, a collaboration between MRC-Technology, UCB and the University of Leicester.

Share this page: